Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.
Also called NCT05572047
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 101 participants
- Sponsor
- Arga Medtech SA
- Registry
-
NCT05572047
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Croatia, Georgia
- Registry status
- Completed
Technical summary
Registry record NCT05572047. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-11 (actual); primary completion 2026-04-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation
- Acronym
- BURST-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System
- Lead sponsor
- Arga Medtech SA
Record details
- Record id
cardio:ct-nct05572047- Content hash
82b84a39ac2fffb768b34f9a714f59e11b3276f8122b1bfc8440480d8719d469